Jakafi 15 MG tablet 60S

Ended Awarded

Contract number
SPE2DR26FBQCZ
Awardee
Awarding agency
Obligated
$12,583

Award facts

Contract value 100% obligated
$12,582.95 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $12,582.95 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on June 1, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for JAKAFI 15 mg tablets.

PPV-G GEN V is a single-award indefinite delivery contract with a $499.999 billion ceiling supporting pharmaceutical and medical consumables supply to Department of Defense military healthcare facilities worldwide. Place of performance is Park Ridge, IL. The order is firm fixed price with an ultimate completion date of June 2, 2026.

Quick answers

Who was awarded contract SPE2DR26FBQCZ?

SPE2DR26FBQCZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 1, 2026.

How much is contract SPE2DR26FBQCZ worth?

The government has obligated $12,583 on SPE2DR26FBQCZ.

Is contract SPE2DR26FBQCZ an order under another contract?

Yes. SPE2DR26FBQCZ is a delivery order under SPE2DR25D9304, an indefinite delivery contract.

Was contract SPE2DR26FBQCZ competed?

The extent of competition for SPE2DR26FBQCZ was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award